Nucleoside analog inhibitors of reverse transcriptase

Details Nucleoside analog inhibitors of reverse transcriptase Nucleoside analog inhibitors of reverse transcriptase

2004-05-19

2009-06-23

Jiang, Shaojia Anna (Department: 1623)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

C514S046000, C514S049000, C514S050000, C536S027200, C536S027300, C536S027810, C536S028530, C536S028540

Reexamination Certificate

active

07550442

ABSTRACT:
Compounds of formula (XXIII), or pharmaceutically acceptable salts or esters thereof, are inhibitors of reverse transcriptase:R4is a nucleoside with Q substituting a 3′ hydroxyl group, and Q is a moiety of formulas (XXIV)-(XXXII):

REFERENCES:
patent: 4522811 (1985-06-01), Eppstein et al.
patent: 5602240 (1997-02-01), De Mesmaeker et al.
patent: 7081449 (2006-07-01), Pietrzkowski et al.
patent: 7285658 (2007-10-01), Cook et al.
patent: 2002/0058635 (2002-05-01), Averett
patent: WO0203997 (2002-01-01), None
Herdewijn et. al. J. Chem. Soc. Perkin. Trans. I, 1994, 249-255.
Selma et. al. Tetrahedron, 52(32) 10785-10798, 1996.
Ashwell et al., “The Synthesis of some Branched-Chain-Sugar Nucleoside Analogues” Nucleoc acids research (1987) vol. 15 No. 5, pp. 2157-2166.
Averett, D.R. 1989. Anti-HIV compound assessment by two novel high capacity assays,J. Virol. Meth.23:263-276.
Barre-Sinoussi, F., J.C. Chermann, F. Rey, M.T. Nugeyre, S. Chamaret, J. Gruest, C. Dauguet, C. Axler-Blin, F. Vezinet-Brun, C. Rouzioux, W. Rozenbaum, and L. Montagnier. 1983. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS).Science.220:868-71.
Beral, V., and R. Newton. 1998. Overview of the epidemiology of immunodeficiency-associated cancers.J Natl Cancer Inst Monogr: 1-6.
Gallo, R.C., S.Z. Salahuddin, M. Popovic, G.M. Shearer, M. Kaplan, B.F. Haynes, T.J. Palker, R. Redfield, J. Oleske, B. Safai, and et al. 1984. Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS.Science.224:500-3.
Hossain, N., A. Papchikhin, N. Garg, I. Fedoriv and J. Chattopadhyaya. 1993. Synthesis of 2′,3′-Dideoxy-3′-Nitro-2′,3′-Didehydrothymidine. Its Use as a General Intermediate for the Preparation of Various 2′,3′-Substituted Nucleosides.Nucleosides&Nucleotides.12:499-528.
Huang, H., R. Chopra, G.L. Verdine, and S.C. Harrison. 1998. Structure of a covalently trapped catalytic complex of HIV-1 reverse transcriptase: implications for drug resistance.Science.282:1669-75.
Huang, J.J., A. Rogouzeos and J.L. Rideout. 1995. A novel synthesis of 3′-deoxy-3′-nitrothymidine via nucleophilic substitution with nitrite anion.J. Heterocyclic Chem.32:691-695.
Huang, P., D. Farquhar, and W. Plunkett. 1990. Selective action of 3′-azido-3′-deoxythymidine 5′-triphosphate on viral reverse transcriptases and human DNA polymerases.J. Biol Chem.265:11914-8.
Lin, T.S., and W.R. Mancini. 1983. Synthesis and antineoplastic activity of 3′-azido and 3′-amino analogues of pyrimidine deoxyribonucleoside.J Med Chem.26:544-8.
Palella, F.J., Jr., K.M. Delaney, A.C. Moorman, M.O. Loveless, J. Fuhrer, G.A. Satten, D.J. Aschman, and S.D. Holmberg. 1998. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators.N Engl J Med.338:853-60.
Prevention, C.f.D.C.a. 1992. Centers for Disease Control and Prevention 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. Morb. Mort. Week Report. 42:1-18.
Wei, X., S.K. Ghosh, M.E. Taylor, V.A. Johnson, E.A. Emini, P. Deutsch, J.D. Lifson, S. Bonhoeffer, M.A. Nowak, B.H. Hahn, and et al. 1995. Viral dynamics in human immunodeficiency virus type 1 infection. Nature. 373:117-22.
Yu, D., et al., “Synthesis of 3′=Cyano-2′,3′-dideoxyadenosine and 2′,3′-Dideoxy-3′-formyladenosine”, American Chemical Society, vol. 54, pp. 3240-3242, (1989).
Lin, T., et al., “Syntheses and Biological Evaluations of 3′-Deoxy-3′-Deoxy-3′-C-Branched-Chain-Substituted Nucleosides”, J. Med. Chem., vol. 36, pp. 353-362, (1993).

Affiliated with

Also associated with

Rating

Nucleoside analog inhibitors of reverse transcriptase does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Nucleoside analog inhibitors of reverse transcriptase, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nucleoside analog inhibitors of reverse transcriptase will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4111994